Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc > Quiet Board

<< Previous

Bullboard Posts

Next >>

Comment by Stocker46on Mar 15, 2021 1:12pm

163 Views

Post# 32799504

RE:RE:RE:RE:RE:RE:RE:Quiet Board

You're just a little delusional stockfy. I had never heard of Cipher before you were pumping it on the CZO board. I've never posted on this board until a few weeks ago.
Seems like you're the one who's desperate to get the SP higher.

If I get the right price I'll buy in .. if not, I'll move on & invest elsewhere .. no big deal.

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals